-
Je něco špatně v tomto záznamu ?
Quantitative nitric oxide production by rat, bovine and porcine macrophages
P Zelnickova, J Matiasovic, B Pavlova, H Kudlackova, F Kovaru, M Faldyna
Jazyk angličtina Země Spojené státy americké
- MeSH
- alveolární makrofágy metabolismus patologie MeSH
- biotest MeSH
- ethylendiaminy MeSH
- financování organizované MeSH
- imunohistochemie MeSH
- interferon gama toxicita MeSH
- ionomycin toxicita MeSH
- krysa rodu rattus MeSH
- kultivované buňky MeSH
- lipopolysacharidy toxicita MeSH
- messenger RNA metabolismus MeSH
- oxid dusnatý analýza metabolismus MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- prasata MeSH
- regulace genové exprese enzymů MeSH
- skot MeSH
- sulfanilamidy MeSH
- synthasa oxidu dusnatého, typ II genetika metabolismus MeSH
- tetradekanoylforbolacetát toxicita MeSH
- western blotting MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- skot MeSH
- zvířata MeSH
The aim of this work was to compare in vitro nitric oxide (NO) production by rat, bovine and porcine macrophages. NO production was induced by lipopolysaccharide (LPS) or by phorbol 12-myristate 13-acetate (PMA) with ionomycin or recombinant interferon gamma (rIFN-gamma) and was assessed by Griess reaction. NO synthase type II (NOS II) expression was quantified by immunocytochemistry, Western blot and real-time polymerase chain reaction (RT-PCR). There were differences in NO production by pulmonary alveolar macrophages (PAM) in all species tested. The largest amounts of NO were produced by rat PAM. Less NO was produced by bovine PAM. Moreover, PAM in rats and cows differed in their abilities to respond to various stimulators. Neither porcine PAM nor Kupffer cells produced NO. Stimulation of porcine PAM with alternative concentrations of LPS did not lead to inducing NO production. Stimulation of porcine PAM with rIFN-gamma together with LPS led to a significant increase in the expression of NOS II mRNA, albeit without detectable NO production or NOS II expression on the protein level.
- 000
- 03155naa 2200565 a 4500
- 001
- bmc11004014
- 003
- CZ-PrNML
- 005
- 20121113122826.0
- 008
- 110303s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ondráčková, Petra $7 xx0165478
- 245 10
- $a Quantitative nitric oxide production by rat, bovine and porcine macrophages / $c P Zelnickova, J Matiasovic, B Pavlova, H Kudlackova, F Kovaru, M Faldyna
- 314 __
- $a Department of Immunology, Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic.
- 520 9_
- $a The aim of this work was to compare in vitro nitric oxide (NO) production by rat, bovine and porcine macrophages. NO production was induced by lipopolysaccharide (LPS) or by phorbol 12-myristate 13-acetate (PMA) with ionomycin or recombinant interferon gamma (rIFN-gamma) and was assessed by Griess reaction. NO synthase type II (NOS II) expression was quantified by immunocytochemistry, Western blot and real-time polymerase chain reaction (RT-PCR). There were differences in NO production by pulmonary alveolar macrophages (PAM) in all species tested. The largest amounts of NO were produced by rat PAM. Less NO was produced by bovine PAM. Moreover, PAM in rats and cows differed in their abilities to respond to various stimulators. Neither porcine PAM nor Kupffer cells produced NO. Stimulation of porcine PAM with alternative concentrations of LPS did not lead to inducing NO production. Stimulation of porcine PAM with rIFN-gamma together with LPS led to a significant increase in the expression of NOS II mRNA, albeit without detectable NO production or NOS II expression on the protein level.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biotest $7 D001681
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a ethylendiaminy $7 D005029
- 650 _2
- $a regulace genové exprese enzymů $7 D015971
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a interferon gama $x toxicita $7 D007371
- 650 _2
- $a ionomycin $x toxicita $7 D015759
- 650 _2
- $a lipopolysacharidy $x toxicita $7 D008070
- 650 _2
- $a alveolární makrofágy $x metabolismus $x patologie $7 D016676
- 650 _2
- $a oxid dusnatý $x analýza $x metabolismus $7 D009569
- 650 _2
- $a synthasa oxidu dusnatého, typ II $x genetika $x metabolismus $7 D052247
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a sulfanilamidy $7 D013424
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a tetradekanoylforbolacetát $x toxicita $7 D013755
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Matiašovic, Ján. $7 _AN050262
- 700 1_
- $a Pavlová, Barbara. $7 _AN058843
- 700 1_
- $a Kudláčková, Hana. $7 _AN059397
- 700 1_
- $a Kovářů, František $7 mzk2005294944
- 700 1_
- $a Faldyna, Martin $7 xx0047099
- 773 0_
- $t Nitric Oxide $w MED00004882 $g Roč. 19, č. 1 (2008), s. 36-41
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110413122720 $b ABA008
- 991 __
- $a 20121113122841 $b ABA008
- 999 __
- $a ok $b bmc $g 831354 $s 696039
- BAS __
- $a 3
- BMC __
- $a 2008 $b 19 $c 1 $d 36-41 $m Nitric oxide $n Nitric oxide $x MED00004882
- LZP __
- $a 2011-3B/ipme